Directory Profile

Program: PhD
Track: Pharmaceutical Outcomes and Policy Research
Advisor: Sandra L. Kane-Gill, PharmD, MS, FCCM, FCCP

Guo Xiaojiang is pursuing her PhD study in Pharmaceutical Outcomes and Policy Research. She earned her Bachelor of Science from China Pharmaceutical University in 2019, afterwards finished her master's study in PSP track from Pitt Pharmacy. Xiaojiang's primary mentors is Drs. Sandra Kane-Gill.

Xiaojiang is focusing on electronic medical records based research to develop medication safety and clinical outcomes which has real-world effects of health and pharmaceutical care, as well as using statistical modeling to develop health outcomes and drug combination effects. She is currently focusing on Acute Kidney Injury associated nephrotoxic drug effects.